161 related articles for article (PubMed ID: 24308883)
1. Digesting the doughnut hole.
Joyce GF; Zissimopoulos J; Goldman DP
J Health Econ; 2013 Dec; 32(6):1345-55. PubMed ID: 24308883
[TBL] [Abstract][Full Text] [Related]
2. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
3. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
J Manag Care Spec Pharm; 2014 Aug; 20(8):862-76. PubMed ID: 25062080
[TBL] [Abstract][Full Text] [Related]
4. Closing the Medicare Doughnut Hole: Changes in Prescription Drug Utilization and Out-of-Pocket Spending Among Medicare Beneficiaries With Part D Coverage After the Affordable Care Act.
Bonakdar Tehrani A; Cunningham PJ
Med Care; 2017 Jan; 55(1):43-49. PubMed ID: 27547949
[TBL] [Abstract][Full Text] [Related]
5. Anticipatory Behavior in Response to Medicare Part D's Coverage Gap.
Kaplan CM; Zhang Y
Health Econ; 2017 Mar; 26(3):338-351. PubMed ID: 26749399
[TBL] [Abstract][Full Text] [Related]
6. Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.
Patel RA; Walberg MP; Tong E; Tan F; Rummel AE; Woelfel JA; Carr-Lopez SM; Galal SM
J Manag Care Spec Pharm; 2014 Mar; 20(3):283-90. PubMed ID: 24564812
[TBL] [Abstract][Full Text] [Related]
7. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
[TBL] [Abstract][Full Text] [Related]
8. Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes.
Fung V; Mangione CM; Huang J; Turk N; Quiter ES; Schmittdiel JA; Hsu J
Health Serv Res; 2010 Apr; 45(2):355-75. PubMed ID: 20050931
[TBL] [Abstract][Full Text] [Related]
9. Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.
Yala SM; Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF
BMC Health Serv Res; 2014 Dec; 14():665. PubMed ID: 25526892
[TBL] [Abstract][Full Text] [Related]
10. Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study.
Safran DG; Strollo MK; Guterman S; Li A; Rogers WH; Neuman P
J Gen Intern Med; 2010 Jan; 25(1):10-7. PubMed ID: 19882193
[TBL] [Abstract][Full Text] [Related]
11. Demand for prescription drugs under non-linear pricing in Medicare Part D.
Jung K; Feldman R; McBean AM
Int J Health Care Finance Econ; 2014 Mar; 14(1):19-40. PubMed ID: 24214101
[TBL] [Abstract][Full Text] [Related]
12. Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis.
Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
J Manag Care Spec Pharm; 2015 Oct; 21(10):956-64. PubMed ID: 26402394
[TBL] [Abstract][Full Text] [Related]
13. Generic-only drug coverage in the Medicare Part D gap and effect on medication cost-cutting behaviors for patients with diabetes mellitus: the translating research into action for diabetes study.
Duru OK; Mangione CM; Hsu J; Steers WN; Quiter E; Turk N; Ettner SL; Schmittdiel JA; Tseng CW
J Am Geriatr Soc; 2010 May; 58(5):822-8. PubMed ID: 20406312
[TBL] [Abstract][Full Text] [Related]
14. Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap.
Polinski JM; Shrank WH; Huskamp HA; Glynn RJ; Liberman JN; Schneeweiss S
PLoS Med; 2011 Aug; 8(8):e1001075. PubMed ID: 21857811
[TBL] [Abstract][Full Text] [Related]
15. The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure.
Baik SH; Rollman BL; Reynolds CF; Lave JR; Smith KJ; Zhang Y
J Ment Health Policy Econ; 2012 Sep; 15(3):105-18. PubMed ID: 23001279
[TBL] [Abstract][Full Text] [Related]
16. Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression.
Zhang Y; Baik SH; Zhou L; Reynolds CF; Lave JR
Arch Gen Psychiatry; 2012 Jul; 69(7):672-9. PubMed ID: 22752233
[TBL] [Abstract][Full Text] [Related]
17. The effects of the coverage gap on drug spending: a closer look at Medicare Part D.
Zhang Y; Donohue JM; Newhouse JP; Lave JR
Health Aff (Millwood); 2009; 28(2):w317-25. PubMed ID: 19189991
[TBL] [Abstract][Full Text] [Related]
18. The impact of Medicare prescription drug coverage on the use of antidementia drugs.
Fowler NR; Chen YF; Thurton CA; Men A; Rodriguez EG; Donohue JM
BMC Geriatr; 2013 Apr; 13():37. PubMed ID: 23621892
[TBL] [Abstract][Full Text] [Related]
19. Prescription Drug Spending and Medication Adherence Among Medicare Beneficiaries with Heart Failure.
McGee BT; Phillips V; Higgins MK; Butler J
J Manag Care Spec Pharm; 2019 Jun; 25(6):705-713. PubMed ID: 31134861
[TBL] [Abstract][Full Text] [Related]
20. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
Blumberg DM; Prager AJ; Liebmann JM
JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
